Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Renal Cell 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Pain 1Neoplasms 1Hematologic Neoplasms 1Encephalitis 1Cerebral Palsy 1Cancer Pain 1Brain Neoplasms 1Arthralgia 1

Interventions

Nivolumab 74Sunitinib 73pembrolizumab 49Everolimus 39Sorafenib 36Bevacizumab 36Axitinib 36cabozantinib 35Radiosurgery 33Ipilimumab 33pazopanib 32Magnetic Resonance Spectroscopy 27Interleukin-2 27aldesleukin 23Specimen Handling 22Cyclophosphamide 21lenvatinib 20fludarabine phosphate 17Radiotherapy 16Interferon-alpha 15Peripheral Blood Stem Cell Transplantation 14Gemcitabine 14Biopsy 14temsirolimus 13Nephrectomy 13durvalumab 11Immunohistochemistry 11CTLA-4 Antigen 11Blood Specimen Collection 11Capecitabine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Renal Cell × Occupational Therapy × Clear all
NCT05519878 2025-12-24

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

City of Hope Medical Center

Phase NA Recruiting
224 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT04961320 2022-06-09

Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell Carcinoma

City of Hope Medical Center

Phase NA Withdrawn
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡